Join Biotts at PODD 2024 conference to witness the transformative potential of MTC-Y transdermal technology. Our innovative platform has demonstrated exceptional capabilities in insulin delivery, paving the way for new possibilities in drug delivery.

We are excited to announce that Biotts will be attending CPHI Milan from October 8th to 10th at Fiera Milano, Italy.

Biotts is excited to announce our participation in the upcoming RESI Conference in Boston! This event is a prime opportunity to engage with early-stage investors and biotech innovators.

We are thrilled to share an important update on our latest innovation in diabetes treatment, featured in our Sunday Express article. Biotts has developed an innovative stick-on patch designed to regulate blood sugar levels more effectively and conveniently than traditional insulin injections.

We are pleased to share the latest in-vivo results from our ongoing research together with Bioton into our innovative transdermal insulin delivery system.

At SusHi Tech Tokyo 2024, our CEO Jan Hendriks provided an insightful presentation on our patented MTC-Y transdermal drug delivery technology and showcases our main 2 projects – Transdermal Insulin and Transdermal Semaglutide.